Laparoscopic ischemic conditioning of the stomach for esophageal replacement

Annals of Surgery

Volumn 245, Issue 2, 2007, Pages 241-246

  Hölscher, Arnulf H ^a,b   Schneider, Paul M ^a   Gutschow, Christian ^a   Schröder, Wolfgang ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Department of Visceral and Vascular Surgery ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; BLEEDING; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CARDIA; CHYLOTHORAX; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGOGASTROSTOMY; ESOPHAGUS NECROSIS; ESOPHAGUS RESECTION; FEMALE; HUMAN; ISCHEMIA; ISCHEMIC PRECONDITIONING; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REOPERATION; STOMACH BLOOD FLOW; STOMACH ISCHEMIA; STOMACH PULL UP; STOMACH SURGERY; SURGICAL APPROACH; SURGICAL PATIENT; SURGICAL STAPLING; THORACOTOMY; THORAX; TISSUE NECROSIS; TISSUE PERFUSION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISCHEMIC PRECONDITIONING; LAPAROSCOPY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STOMACH; TREATMENT OUTCOME;

EID: 33846426446     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000245847.40779.10     Document Type: Article

References (45)

1. Orringer MB, Marshall B, Jannettoni MD. Transhiatal esophagectomy: clinical experience and refinements. Ann Surg. 1999;230:392-403.
2. Ando N, Ozawa S, Kitagawa Y, et al. Improvement in the results of surgical treatment of advanced squamous cell esophageal carcinoma during 15 consecutive years. Ann Surg. 2000;232:225-230.
3. Siewert JR, Stein HJ, Feith M, et al. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the western world. Ann Surg. 2001;234:360-369.
4. Hölscher AH, Schröder W, Bollschweiler E, et al. How safe is high intrathoracic esophagogastrostomy? Chirurg. 2003;74:726-733.
5. McCulloch P, Ward J, Tekkis PP. Mortality and morbidity in gastrooesophageal cancer surgery: initial results of ASCOT multicenter prospective cohort study. BMJ. 2003;327:1192-1197.
6. Rentz J, Bull D, Harpole D, et al. Transthoracic versus transhiatal esophagectomy: a prospective study of 945 patients. J Thorac Cardiovasc Surg. 2003;125:1114-1120.
7. Schäfer H, Engert A, Grass G, et al. Perioperative granulocyte colony-stimulating factor does not prevent severe infections in patients undergoing esophagectomy for esophageal cancer: a randomized placebo-controlled clinical trial. Ann Surg. 2004;240:68-75.
8. Lerut T, Nafteux P, Moons J, et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival and outcome. Ann Surg. 2004;240:962-974.
9. Kaklamanos I, Walker G, Ferry K, et al. Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol. 2003;10:754-761.
10. Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg. 2003;185:538-543.
11. Fiorica F, Di BD, Schepsis F, et al. Preoperative chemoradiotherapy for oesophageal cancer: a systemic review and meta-analysis. Gut. 2004;53:925-930.
12. Greer SE, Goodney PP, Sutton JE, et al. Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis. Surgery. 2005;137:172-177.
13. Valverde A, Hay JM, Fingerhut A, et al. Manual versus mechanical esophagogastric anastomosis after resection for carcinoma: a controlled trial. Surgery. 1996;120:476-483.
14. Briel JW, Tamhankar AP, Hagen JA, et al. Prevalence and risk factors for ischemia, leak and stricture of esophageal anastomosis: gastric pull-up versus colon interposition. J Am Coll Surg. 2004;198:536-541.
15. Liebermann-Meffert DMI, Meier R, Siewert JR. Vascular anatomy of the gastric tube used for esophageal reconstruction. Ann Thorac Surg. 1992;54:1110-1115.
16. Pierie JP, De Graaf PW, Poen H, et al. Impaired healing of cervical esophagogastrostomies can be predicted by estimation of gastric serosal blood perfusion by laser Doppler flowmetry. Eur J Surg. 1994;160:599-603.
17. Urschel JD. Esophagogastrostomy anastomotic leaks complicating esophagectomy: a review. Am J Surg. 1995;169:634-640.
18. Boyle NH, Pearce A, Hunter D, et al. Scanning laser Doppler flowmetry and intraluminal recirculating gas tonometry in the assessment of gastric and jejunal perfusion during oesophageal resection. Br J Surg. 1998;85:1407-1411.
19. Schröder W, Stippel D, Lacher M, et al. Intraoperative changes of mucosal pCO2 during gastric tube formation. Langenbecks Arch Surg. 2001;386:324-327.
20. Schröder W, Beckurts KTE, Stähler D, et al. Microcirculatory changes associated with gastric tube formation in the pig. Eur Surg Res. 2002;34:411-417.
21. Urschel JD. Ischemic conditioning of the rat stomach: implications for esophageal replacement with stomach. J Cardiovasc Surg. 1995;36:191-193.
22. Urschel JD, Antkowiak JG, Delacure MD, et al. Ischemic conditioning (delay phenomenon) improves esophagogastric anastomotic wound healing in the rat. J Surg Oncol. 1997;66:254-256.
23. Schilling MK, Redaelli C, Maurer C, et al. Gastric microcirculatory changes during gastric tube formation: assessment with laser Doppler flowmetry. J Surg Res. 1996;62:125-129.
24. Akiyama S, Ito S, Segikuchi H, et al. Preoperative embolisation of gastric arteries for esophageal cancer. Surgery. 1996;120:542-546.
25. Reavis KM, Chang EY, Hunter JG, et al. Utilization of the delay phenomenon improves blood flow and reduces collagen deposition in esophagogastric anastomoses. Ann Surg. 2005;241:736-747.
26. Schröder W, Stippel D, Gutschow C, et al. Postoperative recovery of microcirculation after gastric tube formation. Langenbecks Arch Surg. 2004;389:267-271.
27. Isomura T, Itoh S, Endo T, et al. Efficacy of gastric blood supply redistribution by transarterial embolisation: preoperative procedure to prevent postoperative anastomotic leaks following esophagoplasty for esophageal carcinoma. Cardiovasc Intervent Radiol. 1999;22:119-123.
28. Schneider PM, Baldus SE, Metzger R, et al. Histomorphologic tumor regression and lymph node metastasis determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification. Ann Surg. 2005;242:684-692.
29. Japanese Gastric Cancer Association. Japanese Classification of Gastric Cancer, 2nd English ed. Gastric Cancer. 1998;1:10-24.
30. Altorki N, Kent M, Ferrera C, et al. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg. 2002;236:177-183.
31. Swanstrom LL, Hanson P. Laparoscopic total esophagectomy. Arch Surg. 1997;132:943-949.
32. Nguyen NT, Follette DM, Wolfe BM, et al. Comparison of minimally invasive esophagectomy with transthoracic and transhiatal esophagectomy. Ann Surg. 2000;135:920-925.
33. Luketich JD, Alvelo-Rivera M, Buenaventura O, et al. Minimal-invasive esophagectomy: outcomes in 222 patients. Ann Surg. 2003;238:486-495.
34. Osugi H, Takemura M, Higashino M, et al. A comparison of video-assisted thoracoscopic oesophagectomy and radical lymph node dissection for squamous cell cancer of the oesophagus with open operation. Br J Surg. 2003;90:108-113.
35. Hulscher JB, Van Sandick JW, de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;347:1662-1669.
36. Cederna PS, Chang P, Pittet-Cuenod BM, et al. The effect of the delay phenomenon on the vascularity of rabbit rectus abdominis muscles. Plast Reconstr Surg. 1997;99:194-205.
37. Dhar SC, Taylor GI. The delay phenomenon: the story unfolds. Plast Reconstr Surg. 1999;104:2079-2091.
38. Lineaweaver WC, Lei MP, Mustain W, et al. Vascular endothelium growth factor, surgical delay and skin flap survival. Ann Surg. 2004;239:866-873.
39. Bollschweiler E, Schröder W, Hölscher AH, et al. Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus. Br J Surg. 2000;87:1106-1110.
40. Bartels H, Stein HJ, Siewert JR. Preoperative risk analysis and postoperative mortality of oesophagectomy for respectable esophageal cancer. Br J Surg. 1998;85:840-4.
41. Stahl M, Stuschke M, Lehmann N, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol. 2005;23:2310-2317.
42. Khuri SF, Henderson WG, DePalma RG, et al. Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg. 2005;242:326-343.
43. Sugimachi K, Kitamura M, Maekawa S, et al. Two-stage operation for poor risk patients with carcinoma of the esophagus. J Surg Oncol. 1987;36:105.
44. Saito T, Shimoda K, Shigemitsu Y, et al. Extensive lymphadenectomy for thoracic esophageal carcinoma: a two-stage operation for high risk patients. Surg Today. 1994;24:610.
45. Stein HJ, Bartels H, Siewert JR. Esophageal cancer: indications for two-stage procedures. Chirurg. 2001;72:881-886.